IPO registrations (S-1, F-1) · Registrants

FF EAI Robotics Ecosystem Inc.

SEC CIK
1460702 · filings on EDGAR ↗
Name on the registration
AIxCrypto Holdings, Inc.
Former names
AIxCrypto Holdings, Inc. (2025–2026); Qualigen Therapeutics, Inc. (2020–2025); RITTER PHARMACEUTICALS INC (2009–2020)
Registration
Form S-1, first filed 2015-03-23, last 2026-09-09; 11 initial registrations, 21 amendments
Outcome
Final prospectus filed 2015-06-26; declared effective 2015-06-24; withdrawal requested 2025-09-24
Industry (SIC)
Finance Services 6199
Incorporated in
DE
Business address
1990 E. GRAND AVENUE, El Segundo, CA 90245
EIN
26-3474527
Ticker
FFR (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
FF EAI Robotics Ecosystem Inc. on the corporate pages

Offering terms

Final price
$5.00 per share (424B4 filed 2015-06-26, an initial public offering)
Shares sold
4,000,000
Gross proceeds
$20,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol RTTR
Lead underwriters
Aegis Capital
Syndicate
Chardan

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 57

FiledFormWhat it isName as filedEDGAR
2015-03-23S-1S-1 (registration)RITTER PHARMACEUTICALS INC0001571049-15-002195 ↗
2015-04-24S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001571049-15-003129 ↗
2015-05-08S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001571049-15-003855 ↗
2015-05-22S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001571049-15-004555 ↗
2015-06-08S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001571049-15-004929 ↗
2015-06-19S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001571049-15-005174 ↗
2015-06-24EFFECTEFFECT (declared effective)RITTER PHARMACEUTICALS INC9999999995-15-001718 ↗
2015-06-26424B4424B4 (final prospectus)RITTER PHARMACEUTICALS INC0001571049-15-005347 ↗
2015-12-31S-1S-1 (registration)RITTER PHARMACEUTICALS INC0001493152-15-006507 ↗
2016-01-19S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001493152-16-006847 ↗
2016-02-11EFFECTEFFECT (declared effective)RITTER PHARMACEUTICALS INC9999999995-16-003737 ↗
2016-06-07EFFECTEFFECT (declared effective)RITTER PHARMACEUTICALS INC9999999995-16-004845 ↗
2016-08-23EFFECTEFFECT (declared effective)RITTER PHARMACEUTICALS INC9999999995-16-005492 ↗
2016-12-16S-1S-1 (registration)RITTER PHARMACEUTICALS INC0001493152-16-015971 ↗
2017-02-09S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001493152-17-001273 ↗
2017-02-13EFFECTEFFECT (declared effective)RITTER PHARMACEUTICALS INC9999999995-17-000367 ↗
2017-07-03S-1S-1 (registration)RITTER PHARMACEUTICALS INC0001493152-17-007461 ↗
2017-07-18S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001493152-17-007882 ↗
2017-07-19S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001493152-17-007981 ↗
2017-09-07S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001493152-17-010318 ↗
2017-09-18S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001493152-17-010706 ↗
2017-09-28S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001493152-17-010992 ↗
2017-09-28S-1/AS-1/A (amendment)RITTER PHARMACEUTICALS INC0001493152-17-011016 ↗
2017-09-28EFFECTEFFECT (declared effective)RITTER PHARMACEUTICALS INC9999999995-17-002493 ↗
2017-09-29S-1MEFS-1MEF (added securities)RITTER PHARMACEUTICALS INC0001493152-17-011060 ↗
2017-10-02424B4424B4 (final prospectus)RITTER PHARMACEUTICALS INC0001493152-17-011152 ↗
2018-11-30EFFECTEFFECT (declared effective)RITTER PHARMACEUTICALS INC9999999995-18-003017 ↗
2019-07-24S-1S-1 (registration)RITTER PHARMACEUTICALS INC0001493152-19-011038 ↗
2019-08-01EFFECTEFFECT (declared effective)RITTER PHARMACEUTICALS INC9999999995-19-001791 ↗
2019-08-01EFFECTEFFECT (declared effective)RITTER PHARMACEUTICALS INC9999999995-19-001792 ↗
2020-04-09EFFECTEFFECT (declared effective)RITTER PHARMACEUTICALS INC9999999995-20-000719 ↗
2022-06-29EFFECTEFFECT (declared effective)Qualigen Therapeutics, Inc.9999999995-22-001926 ↗
2022-08-05EFFECTEFFECT (declared effective)Qualigen Therapeutics, Inc.9999999995-22-002281 ↗
2023-01-05EFFECTEFFECT (declared effective)Qualigen Therapeutics, Inc.9999999995-23-000047 ↗
2023-06-13S-1S-1 (registration)Qualigen Therapeutics, Inc.0001493152-23-021102 ↗
2023-09-07EFFECTEFFECT (declared effective)Qualigen Therapeutics, Inc.9999999995-23-002594 ↗
2023-10-03S-1/AS-1/A (amendment)Qualigen Therapeutics, Inc.0001493152-23-035096 ↗
2024-05-02EFFECTEFFECT (declared effective)Qualigen Therapeutics, Inc.9999999995-24-001339 ↗
2024-05-06S-1/AS-1/A (amendment)Qualigen Therapeutics, Inc.0001493152-24-017806 ↗
2024-08-07S-1/AS-1/A (amendment)Qualigen Therapeutics, Inc.0001493152-24-030612 ↗
2024-08-09S-1/AS-1/A (amendment)Qualigen Therapeutics, Inc.0001493152-24-030954 ↗
2024-08-22S-1/AS-1/A (amendment)Qualigen Therapeutics, Inc.0001493152-24-033560 ↗
2024-09-04EFFECTEFFECT (declared effective)Qualigen Therapeutics, Inc.9999999995-24-002713 ↗
2024-09-06424B4424B4 (final prospectus)Qualigen Therapeutics, Inc.0001493152-24-035279 ↗
2024-10-24S-1S-1 (registration)Qualigen Therapeutics, Inc.0001493152-24-042395 ↗
2024-12-09S-1S-1 (registration)Qualigen Therapeutics, Inc.0001493152-24-049319 ↗
2024-12-19EFFECTEFFECT (declared effective)Qualigen Therapeutics, Inc.9999999995-24-003842 ↗
2025-09-16S-1S-1 (registration)Qualigen Therapeutics, Inc.0001493152-25-013721 ↗
2025-09-24RWRW (withdrawal request)Qualigen Therapeutics, Inc.0001493152-25-014805 ↗
2025-09-26EFFECTEFFECT (declared effective)Qualigen Therapeutics, Inc.9999999995-25-003121 ↗
2025-12-04S-1S-1 (registration)AIxCrypto Holdings, Inc.0001493152-25-026046 ↗
2025-12-11EFFECTEFFECT (declared effective)AIxCrypto Holdings, Inc.9999999995-25-003684 ↗
2026-07-27S-1S-1 (registration)AIxCrypto Holdings, Inc.0001493152-26-034816 ↗
2026-08-18S-1/AS-1/A (amendment)AIxCrypto Holdings, Inc.0001493152-26-039049 ↗
2026-09-04S-1/AS-1/A (amendment)AIxCrypto Holdings, Inc.0001493152-26-041428 ↗
2026-09-09S-1/AS-1/A (amendment)AIxCrypto Holdings, Inc.0001493152-26-041886 ↗
2026-09-14EFFECTEFFECT (declared effective)AIxCrypto Holdings, Inc.9999999995-26-002961 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2015-06-19S-1/Aregistration statement$5.004,000,000$20,000,000Nasdaq RTTR3primary document; price sentence, shares headline, proceeds computed, cover names 3document ↗
2015-06-26424B4final prospectus$5.004,000,000$20,000,000Nasdaq RTTR2primary document; price sentence, shares headline, proceeds table, cover names 2document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Doyle NoahDirector; Director,TenPercentOwner102015–2020
FOEHR MATTHEW WDirector132015–2020
Javelin Venture Partners I SPV I, LLCTenPercentOwner22015
Javelin Venture Partners, L.P.TenPercentOwner42015–2017
Lynn Samuel OOfficerCFO12015
MAIER PAUL VDirector62015–2020
PROEHL GERALD TDirector52015–2018
Ritter Andrew JDirector,Officer; Director,Officer,TenPercentOwner; Officer; Officer,TenPercentOwnerCEO and President; President112015–2020person page Fuzzy
Ritter Ira E.Director; Director,Officer; Director,Officer,TenPercentOwnerCOB, CSO; Exec. Chairman, CSO122015–2022
Step Michael DDirector,OfficerCEO82015–2018person page Fuzzy
Stonehenge Partners LLCTenPercentOwner22015
Mochizuki Ellen F.OfficerVP, Finance32015–2017
Merino William M.Director62017–2020
Benjamin Jeffrey SOfficerVP of Finance22017–2018
Beck John WOfficerChief Financial Officer42018–2020
Abdul-Ahad WajdiOfficerVice President, R & D, CSO; VP, R&D, CSO42020–2022
David Richard A.Director42020–2022
Korenberg Matthew EDirector32020–2022
Kruger Kurt HDirector72020–2022
Lotz Christopher L.OfficerVice President of Finance, CFO; VP of Finance, CFO.52020–2022
Poirier Michael S.Director,OfficerChairman and CEO; Chairman, CEO & President; Chairman, President and CEO; Chairman, President & CEO; Chairman, President & CEO.62020–2022
SEKISUI DIAGNOSTICS, LLCTenPercentOwner22020
Sinha Shishir K.OfficerVice President of Operations; VP, COO & Secretary; VP of Operations42020–2022
BROIDRICK AMY S.Director; Director,OfficerEVP, Chief Strategy Officer; Executive VP, CSO; President/ChiefStrategyOfficer; President/CSO72020–2022
EMERY SIDNEY W JRDirector32020–2022
ARSHAD TARIQOfficerSVP/Chief Medical Officer42021–2022
PRICE CODYDirector12024
BECHER CAMPBELLDirector12024
LIM ROBERT BRADLEYDirector12024
Braeden LichtiDirector12024
Bensler GraydonDirector12024
FARADAY FUTURE INTELLIGENT ELECTRIC INC.TenPercentOwner12025
Wang JiaweiOfficerCo-Chief Executive Officer12025
Shi ChenDirector12026
Dodier Jason EvanDirector12026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2025-08-13Qualigen Therapeutics, Inc.Biotechnology$4,500,000$4,500,000141
2024-11-22Qualigen Therapeutics, Inc.Biotechnology$5,100,000$5,100,000331
2018-11-09RITTER PHARMACEUTICALS INCBiotechnology$6,000,000$6,000,000111
2014-12-16RITTER PHARMACEUTICALS INCPharmaceuticals$5,670,054$3,693,87541
2012-02-23RITTER PHARMACEUTICALS INCOther Health Care$3,500,000$526,44511

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerQualigen Therapeutics, Inc.CAForm D private offeringsCIK (EXACT)
SEC filerAIxCrypto Holdings, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerFF EAI Robotics Ecosystem Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorQUALIGEN THERAPEUTICS, INCEIN (EXACT)
Person pageAndrew J RitterPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer)
Person pageMichael D StepPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Finance Services, CA first:

More with this interest.

In other datasets, the same topic (Finance) in CA:

Interests: Finance Services · Finance